The Application of Nuclear Magnetic Resonance Spectroscopy to Drug Metabolism Studies

References

• Albert K. G., Zeller K. P., Bayer E., Hartmann F. In vivo metabolism of ‘4‐13C’phenacetin in an isolated perfused rat liver measured by continuous flow 13C NMR spectroscopy. Zeitschrift für Naturforschung 1984; 39c: 859–862
   Google Scholar
• Allars H., Coleman M. D., Norton R. S. 1H nuclear magnetic resonance study of metronidazole metabolism by perfused rat liver. European Journal of Drug Metabolism and Pharmacokinetics 1985; 10: 253–260
   PubMed Web of Science ®Google Scholar
• Aubert C., Sommadossi J. P., Coassolo P., Cano J. P., Rigault J. P. Quantitative analysis of 5‐fluorouracil and 5,6‐dihydro‐5‐fluorouracil in plasma by gas chromatography mass spectrometry. Biomedical Mass Spectrometry 1982; 9: 336–339
   PubMedGoogle Scholar
• Avison M. J., Hetherington H. P., Shulman R. G. Applications of NMR to studies of tissue metabolism. Annual Review of Biophysics and Biophysical Chemistry 1986; 15: 377–402
   PubMedGoogle Scholar
• Bales J. R., Sadler P. J., Nicholson J. K., Timbrell J. A. Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy. Clinical Chemistry 1984; 30: 1631–1636
   PubMed Web of Science ®Google Scholar
• Bales J. R., Nicholson J. K., Sadler P. J. Two‐dimensional proton nuclear magnetic resonance “maps” of acetaminophen metabolites in human urine. Clinical Chemistry 1985; 31: 757–763
   PubMed Web of Science ®Google Scholar
• Bales J. R., Bell J. D., Nicholson J. K., Sadler P. J., Timbrell J. A., Hughes R. D., Bennett P. N., Williams R. Metabolic profiling of body fluids by proton NMR: self‐poisoning episodes with paracetamol (acetaminophen). Magnetic Resonance in Medicine 1988; 6: 300–306
   PubMed Web of Science ®Google Scholar
• Bartels M., Albert K., Kruppa G., Mann K., Schroth G., Tabarelli S., Zabel M. Fluorinated psychopharmacological agents: noninvasive observation by fluorine‐19 nuclear magnetic resonance. Psychiatry Research 1986; 18: 197–201
   PubMedGoogle Scholar
• Bernadou J., Armand J. P., Lopez A., Malet‐Martino M. C., Martino R. Complete urinary excretion profile of 5‐fluorouracil during a six‐day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonance. Clinical Chemistry 1985; 31: 846–848
   PubMedGoogle Scholar
• Boyd V. L., Robbins J. D., Egan W., Ludeman S. M. 31P nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites. Journal of Medicinal Chemistry 1986; 29: 1206–1210
   PubMedGoogle Scholar
• Brown F. F., Halsey M. J., Wardley‐Smith B., Martin P. A. Anaesthetic biotransformation investigated with 19F in vivo nuclear magnetic resonance. British Journal of Anaesthesia 1984; 56: 805P–806P
   Google Scholar
• Burt C. T., Moore R. R., Roberts M. F., Brady T. J. The fluorinated anesthetic halothane as a potential NMR biologic probe. Biochimica et Biophysica Acta 1984; 805: 375–381
   PubMedGoogle Scholar
• Cabanac S., Malet‐Martino M. C., Bon M., Martino R., Nedelec J. F., Dimicoli J. L. Direct 19F NMR spectroscopic observation of 5‐fluorouracil metabolism in the isolated perfused mouse liver model. NMR in Biomedicine 1988; 1: 113–120
   PubMedGoogle Scholar
• Chew W. M., Moseley M. E., Mills P. A., Sessler D. I., James T. L., Litt L. Fluorine‐19 spin‐echo magnetic resonance imaging in vivo: spatial distribution of halothane in the rabbit brain. Proceedings of the Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine 1986; 4: 1376–1377
   Google Scholar
• Chew W. M., Moseley M. E., Mills P. A., Sessler D. I., Gonzalez‐Mendez R., James T. L., Litt L. Spin‐echo fluorine magnetic resonance imaging at 2 tesla: In vivo spatial distribution of halothane in the rabbit head. Magnetic Resonance Imaging 1987; 5: 51–56
   PubMedGoogle Scholar
• Coleman M. D., Norton R. S. Observation of drug metabolites and endogenous compounds in human urine by 1H nuclear magnetic resonance spectroscopy. Xenobiotica 1986; 16: 69–77
   PubMed Web of Science ®Google Scholar
• Di Vito M., Podo F., Torosantucci A., Carpinelli G., Whelan W. L., Kerridge D., Cassonne A. A 19F nuclear magnetic resonance study of uptake and metabolism of 5‐fluorocytosine in susceptible and resistant strains of Candida albicans. Antimicrobial Agents and Chemotherapy 1986; 29: 303–308
   PubMedGoogle Scholar
• Everett J. R., Jennings K. R., Woodnutt G., Buckingham M. J. Spin‐echo 1H N.M.R. spectroscopy: a new method for studying penicillin metabolism. Journal of the Chemical Society, Chemical Communications 1984; 894–895
   Google Scholar
• Everett J. R., Jennings K., Woodnutt G. 19F NMR spectroscopy study of the metabolites of flucloxacillin in rat urine. Journal of Pharmacy and Pharmacology 1985; 37: 869–873
   PubMed Web of Science ®Google Scholar
• Evers A. S., Berkowitz B. A., d'Avignon A. Correlation between the anaesthetic effect of halothane and saturable binding in brain. Nature 1987; 328: 157–160
   PubMedGoogle Scholar
• Gochin M., James T. L., Shafer R. H. In vivo 19F‐NMR of 5‐fluorouracil incorporation into RNA and metabolites in Escherichia coli cells. Biochimica et Biophysica Acta 1984; 804: 118–124
   PubMedGoogle Scholar
• Griffiths J. R., Bhujwalla Z., Coombes R. C., Maxwell R. J., Midwood C. J., Morgan R. J., Nias A. H. W., Perry P., Prior M., Prysor‐Jones R. A., Rodrigues L. M., Stubbs M., Tozer G. M. Monitoring cancer therapy by NMR spectroscopy. Annals of the New York Academy of Sciences 1987; 508: 183–199
   PubMedGoogle Scholar
• Heidelberger C., Danenberg P. V., Moran R. G. Fluorinated pyrimidines and their nucleosides. Advances in Enzymology and Related Areas of Molecular Biology, A. Meister. John Wiley, New York 1983; 57–121
   Google Scholar
• Huetter P., Albert K., Bayer E., Zeller K. P., Hartmann F. Generation of formaldehyde by N‐demethylation of antipyrine. Detection of formaldehyde in bile by 13C‐NMR spectroscopy. Biochemical Pharmacology 1987; 36: 2729–2733
   PubMedGoogle Scholar
• Hull W. E. Measurement of absolute metabolite concentrations in biological samples. Bruker Report 1986; 2: 15–19
   Google Scholar
• Hull W. E., Port R., Osswald H., Kunz W., Juretschke H. P., Schuff N. In‐vivo 19F‐NMR study of 5‐fluorouracil metabolism in liver and implanted tumors of the mouse. Proceedings of the Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine 1986; 3: 594–595
   Google Scholar
• Hull W. E., Port R., Kunz W., Schlag P. 19F‐NMR for monitoring 5‐fluorouracil chemotherapy. Proceedings of the Sixth Annual Meeting of the Society of Magnetic Resonance in Medicine 1987; 1: 107
   Google Scholar
• Hull W. E., Kunz W., Port R. E., Seiler N. Chain‐fluorinated polyamines as tumour markers. III. Determination of geminal difluoropolyamines and their precursor 2,2‐difluoro‐putrescine in normal tissues and experimental tumours by in vitro and in vivo 19F NMR spectroscopy. NMR in Biomedicine 1988a; 1: 11–19
   PubMedGoogle Scholar
• Hull W. E., Port R. E., Herrmann R., Britsch B., Kunz W. Metabolites of 5‐fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment. Cancer Research 1988a; 48: 1680–1688
   PubMed Web of Science ®Google Scholar
• Joseph A., Davenport C., Kwock L., Burt C. T., London R. E. Fluorine‐19 NMR studies of tumor‐bearing rats treated with difluoromethyl ornithine. Magnetic Resonance in Medicine 1987; 4: 137–143
   PubMedGoogle Scholar
• Keniry M., Benz C., Shafer R. H., James T. L. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Research 1986; 46: 1754–1758
   PubMed Web of Science ®Google Scholar
• Kestell P., Gill M. H., Threadgill M. D., Gescher A., Howarth O. W., Curzon E. H. Identification by proton NMR of N‐(hydroxymethyl)‐N‐methylformamide as the major urinary metabolite of N,N‐dimethylformamide in mice. Life Sciences 1986; 38: 719–724
   PubMed Web of Science ®Google Scholar
• Knizner S. A., Jacobs A. J., Lyon R. C., Swenberg C. E. In vivo dephosphorylation of WR‐2721 monitored by 31P NMR spectroscopy. Journal of Pharmacology and Experimental Therapeutics 1986; 236: 37–40
   PubMed Web of Science ®Google Scholar
• Koutcher J. A., Barnett D. C., Martin D. S., Stolfi R., Sawyer R., Cowburn D. In‐vivo 19F NMR studies of agents altering 5‐fluorouracil metabolism. Proceedings of the Sixth Annual Meeting of the Society of Magnetic Resonance in Medicine 1987; 1: 108
   Google Scholar
• Litt L., Gonzalez‐Mendez R., James T. L., Sessler D. I., Mills P., Chew W., Moseley M., Pereira B., Severinghaus J. W., Hamilton W. K. An in vivo study of halothane uptake and elimination in the rat brain with fluorine magnetic resonance spectroscopy. Anesthesiology 1987; 67: 161–168
   PubMedGoogle Scholar
• Lotito S., Reutenauer H., Nissou M. F., Decords M., Remy C., Albrand J. P., Francois A., Benabid A. L. Cerebral metabolism of 5 fluorouracil monitored in vivo by 19F NMR spectroscopy in rat. Proceedings of the Thirteenth International Conference on Magnetic Resonance in Biological Systems. 1988; 1–8
   Google Scholar
• Malet‐Martino M. C., Armand J. P., Lopez A., Bernadou J., Beteille J. P., Bon M., Martino R. Evidence for the importance of 5′‐deoxy‐5‐fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometry. Cancer Research 1986a; 46: 2105–2112
   PubMed Web of Science ®Google Scholar
• Malet‐Martino M. C., Faure F., Vialaneix J. P., Palevody C., Hollande E., Martino R. Non invasive fluorine‐19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma. Cancer Chemotherapy and Pharmacology 1986b; 18: 5–10
   PubMedGoogle Scholar
• Malet‐Martino M. C., Servin P., Bernadou J., Armand J. P., Martino R. Human urinary excretion of doxifluridine and metabolites during a 5‐day chemotherapeutic schedule using fluorine‐19 nuclear magnetic tesonance spectrometry. Investigational New Drugs 1987; 5: 273–279
   PubMedGoogle Scholar
• Malet‐Martino M. C., Bernadou J., Martino R., Armand J. P. 19F NMR spectrometry evidence for bile acid conjugates of α‐fluoro‐β‐alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humans. Drug Metabolism and Disposition 1988; 16: 78–84
   PubMedGoogle Scholar
• Martino R., Lopez A., Malet‐Martino M. C., Bernadou J., Armand J. P. Release of fluoride ion from 5′‐deoxy‐5‐fluorouridine, an antineoplastic fluoropyrimidine, in humans. Drug Metabolism and Disposition 1985; 13: 116–118
   PubMedGoogle Scholar
• Martino R., Malet‐Martino M. C., Vialaneix C., Lopez A., Bon M. 19F nuclear magnetic resonance analysis of the carbamate reaction of α‐fluoro‐β‐alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5′‐deoxy‐5‐fluorouridine. Drug Metabolism and Disposition 1987; 15: 897–904
   PubMedGoogle Scholar
• Maxwell R. J., Prior M. J. W., Prysor‐Jones R. A., Griffiths J. R. 19F MRS: a probe of drug uptake and metabolism in vivo. Clinical Science 1986; 70(Suppl. 13)52P–53P
   Google Scholar
• Maxwell R. J., Workman P., Griffiths J. R. Radiosensitiser disposition as monitored by 19F MRS in vivo. Proceedings of the Sixth Annual Meeting of the Society of Magnetic Resonance in Medicine 1987; 2: 974
   Google Scholar
• Metcalfe J. C., Hesketh T. R., Smith G. A. Free cytosolic Ca2+ measurements with fluorine labelled indicators using 19F NMR. Cell Calcium 1985; 6: 183–195
   PubMedGoogle Scholar
• Meynial D., Lopez A., Malet‐Martino M. C., Hoffmann J. S., Martino R. Application of fluorine‐19 nuclear magnetic resonance to the determination of plasma‐protein binding of 5‐deoxy‐5‐fluorouridine, a new antineoplastic fluoropyrimidine. Journal of Pharmaceutical and Biomedical Analysis 1987; 6: 47–59
   Google Scholar
• Mills P., Sessler D. I., Moseley M., Chew W., Pereira B., James T. L., Litt L. An in vivo 19F nuclear magnetic resonance study of isoflurane elimination from the rabbit brain. Anesthesiology 1987; 67: 169–173
   PubMedGoogle Scholar
• Nakada T., Kwee I. L. Noninvasive evaluation of effects of an aldose reductase inhibitor in rat brain by 19F FDG NMR spectroscopy. Magnetic Resonance in Medicine 1987; 4: 366–371, and references cited therein
   PubMedGoogle Scholar
• Nicholson J. K., Timbrell J. A., Bales J. R., Sadler P. J. A high resolution proton nuclear magnetic resonance approach to the study of hepatocyte and drug metabolism. Molecular Pharmacology 1985; 27: 634–643
   PubMedGoogle Scholar
• Nicholson J. K., Wilson I. D. High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development. Progress in Drug Research 1987; 31: 427–479
   PubMedGoogle Scholar
• Nunnally R. L., Babcock E. E., Antich P. The direct observation of 5‐fluorouracil metabolism by the liver in the intact rabbit: a 19F NMR study. Proceedings of the Fourth Annual Meeting of the Society of Magnetic Resonance in Medicine 1985; 2: 810–811
   Google Scholar
• Pass M. A., Geoffrion Y., Deslauriers R., Butler K. W., Smith I. C. P. Use of 13C nuclear magnetic resonance spectroscopy for the evaluation of hepatic drug‐metabolizing enzyme activity in perfused mouse livers. Journal of Biochemical and Biophysical Methods 1984; 10: 135–142
   PubMedGoogle Scholar
• Prior M. J. W., Maxwell R. J., Prysor‐Jones R. A., Stevens A. N., Griffiths J. R. The role of magnetic resonance spectroscopy in assessing drug delivery to tumours. Proceedings of the Fourth Annual Meeting of the Society of Magnetic Resonance in Medicine 1985; 2: 740–741
   Google Scholar
• Prior M. J. W., McSheehy P. M. J., Maxwell R. J., Griffiths J. R. 19F NMR studies of the effect of allopurinol on 5‐fluorouracil metabolism in vivo and in vitro. Proceedings of the Sixth Annual Meeting of the Society of Magnetic Resonance in Medicine 1987; 1: 502
   Google Scholar
• Raleigh J. A., Franko A. J., Treiber E. O., Lunt J. A., Allen P. S. Covalent binding of a fluorinated 2‐nitroimidazole to EMT‐6 tumors in Balb‐C mice: detection by F‐19 nuclear magnetic resonance at 2.35 T. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1243–1245
   PubMedGoogle Scholar
• Schaaf L. J., Ferry D. G., Hung C. T., Perrier D. G., Edwards I. R. Analysis of 5′‐deoxy‐5‐fluorouridine and 5‐fluorouracil in human plasma and urine by high‐performance liquid chromatography. Journal of Chromatography, Biomedical Applications 1985; 342: 303–313
   PubMedGoogle Scholar
• Selinsky B. S., Burt C. T., Thompson M., London R. E. Measurements of in vivo hepatic halothane metabolism in rats using 19F NMR spectroscopy. Proceedings of the Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine 1986; 3: 655–656
   Google Scholar
• Selinsky B. S., Thompson M., London R. E. Measurements of in vivo hepatic halothane metabolism in rats using 19F NMR spectroscopy. Biochemical Pharmacology 1987; 36: 413–416
   PubMedGoogle Scholar
• Smith G. A., Morris P. G., Hesketh T. R., Metcalfe J. C. Design of an indicator of intracellular free Na+ concentration using 19F NMR. Biochimica et Biophysica Acta 1986; 889: 72–83
   PubMedGoogle Scholar
• Stevens A. N., Morris P. G., Iles R. A., Sheldon P. W., Griffiths J. R. 5‐fluorouracil metabolism monitored in vivo by 19F NMR. British Journal of Cancer 1984; 50: 113–117
   PubMed Web of Science ®Google Scholar
• Taylor J. S., Deutsch C. Fluorinated α‐methylamino acids as 19F NMR indicators of intracellular pH. Biophysical Journal 1983; 43: 261–267
   PubMedGoogle Scholar
• Tulip K., Timbrell J. A., Nicholson J. K., Wilson I., Troke J. A proton magnetic resonance study of the metabolism of N‐methylformamide in the rat. Drug Metabolism and Disposition 1986; 14: 746–749
   PubMed Web of Science ®Google Scholar
• Vialaneix J. P., Chouini N., Malet‐Martino M. C., Martino R., Michel G., Lepargneur J. P. Noninvasive and quantitative 19F nuclear magnetic resonance study of flucytosine metabolism in Candida strains. Antimicrobial Agents and Chemotherapy 1986; 30: 756–762
   PubMedGoogle Scholar
• Vialaneix J. P., Malet‐Martino M. C., Hoffmann J. S., Pris J., Martino R. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance. Drug Metabolism and Disposition 1987a; 15: 718–724
   PubMedGoogle Scholar
• Vialaneix J. P., Benjamin A., Malet‐Martino M. C., Martino R., Michel G. Reduction of the antineoplastic fluoropyrimidine, 5‐fluorouracil, to 5,6‐dihydro‐5‐fluorouracil in Escherichia coli. Biotechnology Letters 1987b; 9: 715–720
   Google Scholar
• Von Weymarn C., Aue W. P., Muller S., Seelig J., Romppainen J., Thomson D. In vivo 19F NMR study and imaging of fluorinated anesthetics in a rabbit's brain. Proceedings of the Fifth Annual Meeting of the Society of Magnetic Resonance in Medicine 1986; 1: 253–254
   Google Scholar
• Wolf W., Servis K. L., El‐Tahtawy A. Comparative noninvasive organ monitoring of drug biodistribution and metabolism in humans and rodents: F‐19 NMR spectroscopic studies with 5‐fluorouracil. Proceedings of the Sixth Annual Meeting of the Society of Magnetic Resonance in Medicine 1987a; 2: 587
   Google Scholar
• Wolf W., Albright M. J., Silver M. S., Weber H., Reichardt U., Sauer R. Fluorine‐19 NMR spectroscopic studies of the metabolism of 5‐fluorouracil in the liver of patients undergoing chemotherapy. Magnetic Resonance Imaging 1987b; 5: 165–169
   PubMed Web of Science ®Google Scholar
• Wolf W., Albright M. J., Sauter R., Reichardt U., Silver M., Weber H., Sauer R. Non‐invasive studies of drug biodistribution and metabolism: NMR spectroscopy of 5‐fluorouracil in patients with squamous cell carcinoma of the head and neck. Proceedings of the American Association for Cancer Research. 1987c; 189
   Google Scholar
• Wyrwicz A. M., Pszenny M. H., Schofield J. C., Tillman P. C., Gordon R. E., Martin P. A. Noninvasive observations of fluorinated anesthetics in rabbit brain by fluorine‐19 nuclear magnetic resonance. Science 1983; 222: 428–430
   PubMed Web of Science ®Google Scholar
• Wyrwicz A. M., Pszenny M. H., Nichols B. G., Tillman P. C. In vivo 19F NMR study of halothane and isoflurane elimination from a rabbit brain. Anesthesiology 1984; 61: A156
   PubMedGoogle Scholar
• Wyrwicz A. M., Conboy C. B., Ryback K. R., Nichols B. G., Eisele P. In vivo 19F‐NMR study of isoflurane elimination from brain. Biochimica et Biophysica Acta 1987a; 927: 86–91
   PubMedGoogle Scholar
• Wyrwicz A. M., Conboy C. B., Nichols B. G., Ryback K. R., Eisele P. In vivo 19F NMR study of halothane distribution in brain. Biochimica et Biophysica Acta 1987b; 929: 271–277
   PubMedGoogle Scholar
• Zeller K. P., Hutter P., Albert K., Hartmann F., Bayer E. In vivo metabolism studied by 13C‐labelling. New Trends in Natural Products Chemistry, P. W. Attaur-Rahman, Le Quesne. Elsevier, Amsterdam 1986; Vol. 26: 661–671
   Google Scholar